Hepatocarcinogenicity of griseofulvin following parenteral administration to infant mice.
D000818:Animals; D000831:Animals, Newborn; D002273:Carcinogens; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006118:Griseofulvin / Q000633:toxicity; D007263:Infusions, Parenteral; D008113:Liver Neoplasms; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced*
D002273:Carcinogens; D006118:Griseofulvin